ONCO
Onconetix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.43
−10.13%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$45.0K
- Revenue estimate
- $17.5K
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$1.28
- EPS estimate
- -$4.5K
- Revenue actual
- $17.1K
- Revenue estimate
- $18.3K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +25.5%
- Revenue beats (12Q)
- 1
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$4.5K | -$1.28 | Beat 99.97% | $17.1K |
| May 13, 2026 | — | -$6.71 | — | $21.5K |
| Mar 12, 2026 | — | $6.05 | — | $303.6K |
| Nov 13, 2025 | — | -$6.25 | — | $303.7K |
| Aug 14, 2025 | — | -$4.05 | — | $106.5K |
| Jun 12, 2025 | — | $21 | — | $101.6K |
| Dec 9, 2024 | — | -$2.24 | — | $406.9K |
| Aug 29, 2024 | — | -$9.20 | — | $704.8K |
| May 20, 2024 | -$8.40 | -$6.40 | Beat 23.81% | $700.4K |
| Mar 9, 2024 | — | -$1.00 | — | $58.5K |
| Nov 17, 2023 | -$0.19 | -$0.28 | Miss -47.37% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026